CURRENT MEDICAL RESEARCH AND OPINION, cilt.20, sa.4, ss.533-540, 2004 (SCI-Expanded)
Objective: Constitutive activation of various hormone and growth factor receptors is newly recognised as a common cause of tumour development. This study investigated the presence of any mutation or polymorphism of prolactin receptor (PRLR) in 38 patients with breast cancer.